发布时间：2025-12-05 09:59 ‘BBB’ long-term issuer credit rating from S&P Global Ratings
Positive outlook, reflecting expected profitability improvement, ramp up of Nemluvio, and continued deleveraging and balance sheet improvement
Recognition of Galderma’s science-based dermatology portfolio and global operations



ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook.

The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. S&P notes the company’s well-established brand portfolio, global footprint, including an expanding presence in emerging markets, and continued investment in science-based innovation.

S&P high
=*=*=*=*=*=
当前为第1/6页
下一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页